Navigation Links
GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
Date:1/3/2008

h-based pharmaceutical and healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit http://www.gsk.com.

About Theravance

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction. Of the six programs in development, four are in late stage -- its telavancin program focusing on treating serious Gram-positive bacterial infections with Astellas Pharma Inc., the Gastrointestinal Motility Dysfunction program, the Horizon program (Beyond Advair collaboration) with GlaxoSmithKline, and TD-1792 for the treatment of serious Gram-positive bacterial infections. By leveraging its proprietary insight of multivalency toward drug discovery focused on validated targets, Theravance is pursuing a next generation strategy designed to discover superior medicines in areas of significant unmet medical need. For more information, please visit the company's web site at http://www.theravance.com. THERAVANCE(R), the Theravance logo, and MEDICINES THAT MAKE A DIFFERENCE(R) are registered trademarks of Theravance, Inc.

GlaxoSmithKline Forward-Looking Statements

Under the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995, the company cautions investors that any forward-looking statements or projections made by the company, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect the Group's operations are described under 'Ri
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
2. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
3. GlaxoSmithKline Accelerates Review of Exelixis XL880
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
7. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
8. FASgen Announces a New Discovery in Obesity Research
9. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
10. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
11. FASgen Announces New Discovery for Treatment of Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... OREM, Utah , May 22, 2013  Aribex, ... handheld X-ray system, today introduced a new color option, ... into the U.S. dental and veterinary markets. The popular ... released last month will continue to be available and ... equipment dealers. (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) ...
(Date:5/22/2013)... Conn. , May 22, 2013 /PRNewswire-iReach/ -- ... stay aligned with the latest trends and events, ... that can predict where an industry is headed ... evolve. (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... partnership with market research publisher GlobalData, offer decision ...
(Date:5/22/2013)... 22, 2013  The Leukemia & Lymphoma Society (LLS) ... Biotherapeutics, LLC, a joint venture between ImmunGene and Caliber, ... a Phase I clinical trial for a novel fusion ... many patients with indolent lymphomas who do not respond ... protein, IGN002, is a new class of biotherapeutics produced ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... 2011 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... Executive Officer of Neurocrine Biosciences, will be presenting at ... New York.    The live presentation takes place ... Time / 8:00 a.m. Pacific Time.  The presentation will ...
... Nov. 23, 2011 Dune Medical Devices, Inc. today ... the 23rd Annual Piper Jaffray Healthcare Conference and will ... PM on Wednesday, November 30, 2011. The ... & 30, 2011 at the New York Palace Hotel, ...
Cached Medicine Technology:
(Date:5/22/2013)... May 23, 2013 The Yoga of Lady Niguma ... a thousand years ago. This is the oldest yoga found ... , Lady Niguma was the partner of renowned Indian master and ... series specifically designed by a female yoga master. , Lady ... turn passed it on through a long lineage to the second ...
(Date:5/22/2013)... 2013 A new study published online today ... of young people who visited fast food or chain restaurants ... obese were more likely to use calorie information given in ... that young people eating at fast food or chain restaurants ... use calorie information as those eating there once a week ...
(Date:5/22/2013)... Hosted by the California Dental Association Foundation ... more than $1.6 million in charitable dental services during ... , The California Dental Association Foundation and the ... dental services and oral health education to Californians who ... held by CDA and CDAF in the past 12 ...
(Date:5/22/2013)... 2013 Zensah® Compression Apparel released a ... titled "Breast pain while running affects one-third ... could help." According to the article, a British study ... amount suffer from breast pain while running but do ... issue. , Zensah emphasizes the importance for women ...
(Date:5/22/2013)... Dennis Thompson HealthDay Reporter , , WEDNESDAY, May ... or back pain are more likely to attempt suicide, ... another psychiatric condition, according to a new study. ... should be aware they are at increased risk of ... Affairs Serious Mental Illness Treatment Resource and Evaluation Center ...
Breaking Medicine News(10 mins):Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3
... failing to meet national goals in treating many heart ... Johns Hopkins researchers published in the October issue of ... that also found care levels dependent on race, geography ... of 1,492 heart attack patients and 3,955 pneumonia patients ...
... -- High-blood-pressure patients treated for enlarged heart (left ... of LVH may also have a better chance ... Hospital/Weill Cornell Medical Center, the research is published ... American Heart Association (AHA). , An estimated 20 ...
... TSX, MONTREAL, Oct. 31 /PRNewswire-FirstCall/ - Haemacure ... of,its presentation at the Acumen BioFin Rodman & ... at 11:30 a.m. at the New York,Palace Hotel ... webcast the audio portion of the presentation and,post ...
... Response Genetics, Inc.,(Nasdaq: RGDX ) today announced ... overview, including an update on its ERCC-1,molecular diagnostic gene ... Conference at the San Diego Marriot Del,Mar in San ... present at,5:30 p.m. PT Thursday, Nov. 1. The ...
... Study finds 10% improvement with cholesterol drugs , , WEDNESDAY, ... statins to lower their cholesterol had a 10 percent ... radiation therapy 10 years after diagnosis, a new study ... but falls short of supporting statin use for all ...
... Plan in Pennsylvania, PITTSBURGH, Oct. 31 U.S. ... Assurance (NCQA) recently released its third,report on health plans, ... Gateway Health Plan is ranked #12 among 196 Medicaid,plans ... "Gateway Health Plan is extremely proud to once ...
Cached Medicine News:Health News:Heart attacks/pneumonia falls short of national goals 2Health News:Preventing or reducing enlarged heart may decrease risk for diabetes 2Health News:Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec 2Health News:Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference 2Health News:Better Prostate Cancer Survival for Men Taking Statins 2Health News:Gateway Health Plan Ranked Again Among 'America's Best Health Plans' According to U.S. News & World Report, NCQA 2
Angled Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Curved shafts and tips with 6.5 mm tying platform. Flat serrated handle with dull finish. Overall length 4.0 inches....
Angled 45 degree shafts 10 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Angl...
Medicine Products: